Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ID Experts Pan Trump Order Calling for Forced Hospitalization of Homeless People

President Trump’s recent executive order encouraging involuntary commitment of people with mental illness who are homeless provoked a swift response from infectious disease experts, who warned that such moves could disrupt care for conditions ranging from HIV to hepatitis C in already vulnerable communities. The order — entitled “Ending Crime and Disorder on America’s Streets” […]

Investigational Immunotherapy Combo Shows Promise for Advanced Solid Tumors

An investigational combination of CTLA-4 and PD‐1 checkpoint inhibitors demonstrated “encouraging” tumor activity, as well as a manageable safety profile, in patients with advanced/metastatic solid tumors, according to results from a small phase I study. Among 61 patients with different solid tumors who were evaluated for efficacy, 37.7% achieved an objective response to treatment with […]

Healthcare Mergers Need More Regulation and Oversight, Senators Told

Congress must act to rein in consolidation in the healthcare system while still encouraging competition, Shawn Martin of the American Academy of Family Physicians (AAFP) said Thursday during a Senate hearing. “A competitive healthcare marketplace benefits patients,” Martin, executive vice president and CEO of the AAFP, in Leawood, Kansas, said at a Senate Finance Committee […]

Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancer

SAN FRANCISCO — Pembrolizumab (Keytruda) monotherapy showed encouraging antitumor activity in patients with papillary high-risk non-muscle-invasive bladder cancer (HR NMIBC) that was unresponsive to Bacillus Calmette-Guerin (BCG) treatment. In a cohort of patients in the KEYNOTE-057 study who had 45 months of follow-up, those treated with pembrolizumab (n=32) had an estimated 12-month disease-free survival (DFS) […]

Existing Drugs Could Treat Lung Cancer in Nonsmokers

Latest Cancer News MONDAY, Oct. 4, 2021 There’s some encouraging news for people who develop lung cancer even though they’ve never smoked. Precision drugs already approved by the U.S. Food and Drug Administration can be used to treat 78% to 92% of their tumors, a new study reports. These precision drugs target specific […]

DBN Health News